All it took for me to make the permanent switch to Brave on my Android was opening the settings window and scrolling through one particular section. I’ve been using a combination of Firefox and Opera ...

EXCLUSIVE: Here’s the trailer for Pablo Larraín’s Netflix miniseries My Sad Dead. Based on stories by acclaimed Argentine author Mariana Enriquez, the psychological horror will play in competition at ...

For years, Brave's browser has been a popular security-first alternative to Chrome. Now it's protecting your email address. Avishek Das/SOPA Images/LightRocket/Getty Images Have you ever received the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Eli Lilly remains on a shopping spree, agreeing to pay up to $2.875 billion in cash for biotechnology company Merida Biosciences in a deal that bolsters the drugmaker’s immunology portfolio. Eli Lilly ...

Eli Lilly has continued its lengthy streak of acquisitions in 2026 with a $2.88 billion agreement to buy immunology and inflammation specialist Merida Biosciences. If it goes through, the deal will ...

Acquisition strengthens Lilly's immunology capabilities and its opportunity to elevate the standard of care for immune-mediated conditions with high unmet need INDIANAPOLIS and CAMBRIDGE, Mass., Aug.

Eli ⁠Lilly said on Monday it would acquire privately held Merida Biosciences for up to $2.88 billion in cash, strengthening its immunology portfolio with an experimental treatment for thyroid-related ...

Deal helps Lilly expand immunology pipeline, diversify beyond obesity drugs Merida's lead drug candidate targets Graves' disease and thyroid eye disease Transaction valued at up to $2.88 billion in ...

The deal feeds Eli Lilly’s voracious appetite for assets. (Angus Liu/Fierce Pharma) Eli Lilly has struck a deal to acquire Merida Biosciences for up to $2.875 billion, establishing a beachhead in its ...

Eli Lilly will pay up to $2.875B to acquire Merida, expanding its immunology pipeline with a mechanism focused on eliminating disease-causing autoantibodies rather than broadly suppressing immunity.

Add Yahoo as a preferred source to see more of our stories on Google. Sad woman at the beach A much-loved school teacher and dad of four recently gave his own life to save a total stranger from a very ...